Pharmacist inquiries to doctors reduced opioid prescriptions

Pharmacist intervention on high risk users associated with reduced use and cost

April 21, 2015

Pharmacist intervention associated with reduced use and cost of controlled substances among high risk users

Pharmacists flagged the files of Medicare members with high controlled substance (CS) scores. A CS score combines a weighted mix of :
1) volume of controlled substance claims,
2) number of prescribers and pharmacies, and
3) rate of utilization of controlled substances.

Those members’ doctors were contacted to verify if the CS therapy was still appropriate or if changes were needed. Of the members who met study criteria, half had doctor-directed changes to therapy. This decreased members’ average CS scores by 40%.

Outcomes of an opioid overutilization pharmacist consultation program (Spring 2014)

Related news

Perspectives

July 25, 2024

Quarterly Drug Pipeline: July 2024

Clinical insights and competitive intelligence on anticipated drugs in development

Perspectives

July 22, 2024

Oncology Insights: 2024 ASCO Annual Meeting key findings

Findings from this year’s American Society of Clinical Oncology (ASCO) Annual Meeting will likely lead to clinical practice changes and U.S. Food and Drug Administration (FDA) drug approvals or expansions

Perspectives

July 16, 2024

LISTEN NOW: Beyond the business – Stories of corporate kindness | Pharmacy Friends Podcast

In this episode, we talk about how our employees' help goes beyond our work in health care, aiding in philanthropic efforts